Search results for: pediatric trials

Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)

THIS IS NOT A REQUEST FOR PROPOSALS (RFP). THIS IS A PRE-SOLICITATION ANNOUNCEMENT ONLY. AN RFP WILL BE ISSUED VIA FEDBIZOPPS ON OR ABOUT NOVEMBER 3, 2017.Background:The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to solicit proposals to establish an Indefinite-delivery, Indefinite-quantity (IDIQ) Task Order (TO) contract to support clinical activities for continuing the Pediatric Trials Network (PTN). The successful offeror shall provide the requisite personnel, facilities and services to establish, conduct, and support pediatric clinical trials and related services including: expert consultation; pediatric clinical pharmacology; product formulation; dru...

The primary scope of the Pediatric Early Phase Clinical Trials Network (PEP-CTN) is to design and conduct pediatric phase 1 trials that will often include phase 2 expansion cohorts. Conduct of the phase 2 study components within the PEP-CTN is efficient and allows intensive study monitoring for toxicity for these agents undergoing their initial evaluation in children.

Contact Information: Angela Wish, Contract Specialist, Phone 301-435-6947, Email angela.wish@nih.gov - Alice M Pagan, Contract Specialist, Phone 301-435-6959, Email alice.pagan@nih.gov Office Address :Contracts Management Branch6710B Rockledge Dr., Suite 1124, MSC7000 Bethesda MD 20892-7510 Location: National Institute of Child Health and Human Development Set Aside: Award Number: HHSN275201800003I Award Amount : IDIQ Ceiling Amount - $96,000,000; Task Order 1 Amount - $1,014,917 Award Date: 060418 Awardee: Duke University, 2200 West Main Street, Suite 900, Durham, NC 27705 US

The Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), within the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, intends to extend at no additional cost for 9 months on a sole source basis, under the authority of 41 U.S.C. 3304(a)(1) as set forth in Federal Acquisition Regulation (FAR) 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements,” a COVID-19 project to complete the Multi-Inflammatory Syndrome in Children (MIS-C) Data Platform Pilot project – COVID-19 Related Action that is currently being performed under the Best Pharmaceuticals for Children Act (BPCA) Data Coordinating Center (DCC) e...

It is critical that the services and work provided by Westat, Inc., not be interrupted as they are integral part to the success of the MPIDB pediatric and maternal clinical trials currently awarded and ongoing on the IDIQ contract.As the incumbent Contractor, Westat conducts research and performs clinical trials, develops and carries out other research protocols, and provides necessary logistical, technical, administrative, and other support to maintain

The NICHD Network enrolls patients into trials conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) network, the Adult AIDS Clinical Trials Group (AACTG) funded by the National Institute of Allergy and Infectious Diseases (NIAID), and the NICHD-funded Adolescent HIV Medicine Trials Network (ATN).